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Abstract
There is growing evidence that interneurons (INs) orchestrate neural activity and plasticity in corticoamygdala
circuits to regulate fear behaviors. However, defining the precise role of cholecystokinin-expressing INs (CCK INs)
remains elusive due to the technical challenge of parsing this population from CCK-expressing principal neurons
(CCK PNs). Here, we used an intersectional genetic strategy in CCK-Cre;Dlx5/6-Flpe double-transgenic mice to
study the anatomical, molecular and electrophysiological properties of CCK INs in the basal amygdala (BA) and
optogenetically manipulate these cells during fear extinction. Electrophysiological recordings confirmed that this
strategy targeted GABAergic cells and that a significant proportion expressed functional cannabinoid CB1
receptors; a defining characteristic of CCK-expressing basket cells. However, immunostaining showed that
subsets of the genetically-targeted cells expressed either neuropeptide Y (NPY; 29%) or parvalbumin (PV; 17%),
but not somatostatin (SOM) or Ca2/calmodulin-dependent protein kinase II (CaMKII)-. Further morphological
and electrophysiological analyses showed that four IN types could be identified among the EYFP-expressing
cells: CCK/cannabinoid receptor type 1 (CB1R)-expressing basket cells, neurogliaform cells, PV basket cells,
and PV axo-axonic cells. At the behavioral level, in vivo optogenetic photostimulation of the targeted population
during extinction acquisition led to reduced freezing on a light-free extinction retrieval test, indicating extinction
memory facilitation; whereas photosilencing was without effect. Conversely, non-selective (i.e., inclusive of INs
and PNs) photostimulation or photosilencing of CCK-targeted cells, using CCK-Cre single-transgenic mice,
Significance Statement
Distinct types of interneurons (INs) in the basal amygdala (BA) are known to control principal cell activity,
allowing complex behaviors. Despite their importance, the role of cholecystokinin (CCK)-expressing inhib-
itory cells remains unknown. In this work, we could specifically alter the function of CCK-expressing INs in
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impaired extinction. These data reveal an unexpectedly high degree of phenotypic complexity in a unique
population of extinction-modulating BA INs.
Key words: basolateral amydala; emotional circuits; inhibitory cells; excitatory cells; mouse
Introduction
The basolateral amygdala complex is a neural structure
subserving a range of behavioral functions and neural
processes, including emotional regulation, and is impli-
cated in the pathophysiology of anxiety and trauma-
related disorders (Bukalo et al., 2014; Tovote et al., 2015).
The amygdala is comprised of an assortment of cells
which differ in their neurochemical identity and efferent
and afferent connectivity, but the functional contribution
of specific neuronal subpopulations to fear and extinction
remains to be fully elucidated (Janak and Tye, 2015).
Within the basal nucleus of the amygdala (BA), as in other
cortical structures, the activity of principal neurons (PNs)
is tightly regulated by local inhibitory GABAergic interneu-
rons (INs) and there is growing evidence that local INs
provide a critical regulatory component of the circuits
mediating fear and extinction (Ehrlich et al., 2009; Mc-
Cullough et al., 2016; Krabbe et al., 2018; Lucas and
Clem, 2018).
Although INs represent a highly diverse set of cell types,
there are evolving efforts to classify them based on their
morphologic features, physiologic characteristics and
molecular phenotype (DeFelipe et al., 2013). One com-
monly adopted method segregates IN subpopulations
based on neurochemical content, including expression of
Ca2-binding proteins [e.g., parvalbumin (PV); McDonald
and Betette, 2001; McDonald and Mascagni, 2001b] and
neuropeptides such as somatostatin (SOM), neuropeptide
Y (NPY), and cholecystokinin (CCK; Mascagni and Mc-
Donald, 2003; Kepecs and Fishell, 2014). In turn, there is
emerging evidence for critical contributions of some of
these subpopulations to fear behaviors. For example, an
elegant series of studies has shown that PV-containing
and SOM-containing BA INs act in concert to gate the
responses of PNs to conditioned stimulus (CS) and un-
conditioned stimulus (US) during fear memory acquisition
(Wolff et al., 2014). However, the possible roles of other
subpopulations of BA INs, including NPY-expressing
(Ma nko et al., 2012) and CCK-expressing (Rovira-Esteban
et al., 2017), in regulating fear and extinction remain un-
clear.
Adding to the complexity of studying CCK INs, within
the BA these cells appear to fall into subclasses that are
differentially positioned within the broader extinction cir-
cuitry. In rodent BA, CCK INs with large soma (CCK-L)
express either vesicular glutamate transporter type 3
(VGluT3) or Ca2 binding protein, calbindin (Calb) and are
distingushed from NPY-expressing CCK INs with small
soma (CCK-S) (Mascagni and McDonald, 2003; Omiya
et al., 2015; Vogel et al., 2016; Rovira-Esteban et al.,
2017; Veres et al., 2017). BA CCK-L INs make
functionally-potent perisomatic connections onto BA PNs
(Vereczki et al., 2016; Andrási et al., 2017; Barsy et al.,
2017; Veres et al., 2017) that in turn project to the dmPFC
and vmPFC (Vogel et al., 2016). Interestingly, extinction
recruits CCK-L INs targeting the extinction-constraining
BA¡dmPFC pathway (Trouche et al., 2013; Senn et al.,
2014; Vogel et al., 2016). Moreover, CCK-L express the
cannabinoid receptor type 1 (CB1R) on their axonal vari-
cosities (Marsicano and Lutz, 1999; Katona et al., 2001;
McDonald and Mascagni, 2001a; Mascagni and McDon-
ald, 2003; Yoshida et al., 2006; Bowers and Ressler,
2015). Of note here, previous studies have shown that
cannabinoid signaling at BA CB1Rs promotes fear extinc-
tion (Marsicano et al., 2002; Chhatwal et al., 2005;
Gunduz-Cinar et al., 2013), an effect that is known to
depend at least to some extent on receptors expressed at
GABAergic axon terminals (Ruehle et al., 2013).
Taken together, the current literature support the hy-
pothesis that CCK INs affect extinction by dynamically
adjusting the balance of inhibitory control over opposing
BA output-pathways (Vogel et al., 2016). In this context,
the goal of the current study was to further characterize
the electrophysiological, morphological and molecular
properties of CCK INs in the BA and assess their contri-
bution to fear extinction. To this end, we employed an
intersectional approach (Fenno et al., 2014) to genetically
access and manipulate BA CCK INs (Taniguchi et al.,
2011; Senn et al., 2014; Whissell et al., 2019).
Materials and Methods
Subjects
C57BL/6J (JAX stock #000664), CCK-IRES-Cre
(Ccktm1.1(cre)Zjh/J, JAX stock #012706) and Dlx5/6-Flpe
(Tg(mI56i-flpe)39Fsh/J, JAX stock #010815) mice were
obtained from The Jackson Laboratory. Homozygous
Cck-Cre and homozygous Dlx5/6-Flpe mice were bred to
produce CckCre;Dlx5/6Flp (CCK IN) mice. Males and fe-
males were used for electrophysiological recordings and
male mice were used for behavioral testing. Mice were
housed in same-sex groupings (two to four per cage);
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mice with chronic fiber implantations for in vivo optoge-
netics were single-housed after surgery to prevent cage-
mates damaging the cranial implants. Housing was in a
temperature- and humidity-controlled vivarium under a
12/12 h light/dark cycle (lights on 6 A.M.). Experiments
were conducted during the light phase.
All experimental procedures were performed in accor-
dance with the Institutional Ethical Codex, Hungarian Act
of Animal Care and Experimentation (1998. XXVIII. section
243/1998, renewed in 40/2013), the European Union
guidelines (directive 2010/63/EU), the National Institute of
Health (NIH) Guide for the Care and Use of Laboratory
Animals and approved by the Institutional Animal Care
and Use Committee of the Institute of Experimental Med-
icine and the local National Institute on Alcohol Abuse and
Alcoholism (NIAAA) and Vanderbilt Animal Care and Use
Committees.
Stereotaxic surgery
Mice were placed in a stereotaxic frame (David Kopf
Instruments) to bilaterally inject viral constructs into the
BA (coordinates: anterior-posterior –1.4 to 1.5 mm,
medial-lateral 3.22 to 3.3 mm, dorsal-ventral –4.4 to
4.85 mm to bregma). Virus was injected in a volume of 0.2
l per hemisphere at a rate of 3 nl/s (for ex vivo optoge-
netics) or in a volume of 0.4–0.5 l per hemisphere over
10 min (for in vivo optogenetics), according to each lab-
oratory’s local practices and pilot work. Injections were
done using a 1-l syringe (Neuros model 7001 KH, Ham-
ilton Robotics) connected to a UMP3 UltraMicroPump
and SYS-Micro4 Controller or Nanoliter NL2010MC4 in-
jector (World Precision Instruments, LLC). The syringe
was left in place for an additional 5 min to ensure con-
structs diffused into the tissue. For in vivo optogenetics,
during the same surgery as viral injections, ferrules and
200-m diameter fiber optics (numerical aperture, 0.37)
were bilaterally inserted into the BA and affixed to the
skull with dental cement. The ferrule-fiber assembly was
constructed according to previously published methods
(Bukalo et al., 2015; Bergstrom et al., 2018; Radke et al.,
2019).
Viral constructs
Adenoassociated virus (AAV)-based constructs engi-
neered to transfect Cre cells with channelrhodopsin-2
(ChR2; AAV5-EF1a-DIO–hChR2(H134R)-EYFP), archaer-
hodopsin (eArch3.0; AAV5-EF1a-DIO-eArch3.0-EYFP), or
control vector (AAV5-EF1a-DIO-EYFP) were obtained
from the University of North Carolina Vector Core. The
AAV-based INTRSECT (INTronic Recombinase Sites En-
abling Combinatorial Targeting)-related constructs engi-
neered to transfect Cre/Flp cells with ChR2 (AAVdj-
hSyn-Con/Fon-hChR2(H134R)-EYFP-WPRE in ex vivo
experiments, and pAAV-nEF1-Con/Fon-hChR2(H134R)-
EYFP-WPRE in behavior experiments, hereafter referred
to as INTRSECT-ChR2), Arch3.3 (AAVdj-hSyn-Con/Fon-
Arch3.3-EYFP, hereafter referred to as INTRSECT-Arch)
or a control virus nEF-Con/Fon-eYFP-WPRE were ob-
tained from the University of North Carolina Vector Core
or directly from the Deisseroth laboratory. The virus titers
were 3–6  10e12 vg/ml.
Fluorescence in situ hybridization
At least five weeks after delivery of AAVdj-hSyn-Con/
Fon-hChR2(H134R)-EYFP-WPRE, CCK IN mice were
killed by cervical dislocation, then brains were immedi-
ately removed and frozen in 2-methyl butane on dry ice
and stored at –80°C. Coronal sections, 16-m-thick,
were cut using a cryostat (model HM500 OM, Microm
International GmbH) and mounted directly onto Super
Frost Plus slides (Fisher Scientific) and maintained at
–20°C before transfer to a staining jar containing 4°C 10%
buffered formalin solution. After a 20-min fixation, slides
were rinsed twice in PBS for 1 min each, then dehydrated
in an ethanol dilution series (50%, 70%, and 100% 2)
and stored at –20°C overnight in 100% ethanol.
The following day, the sections were processed using
an RNAscope Fluorescent Multiplex Assay kit (Advanced
Cell Diagnostics USA; Gunduz-Cinar et al., 2019) accord-
ing to the manufacturer’s instructions. Slides were first air
dried for 10 min, then a hydrophobic barrier drawn around
each section with an ImmEdge barrier pen (Vector Labo-
ratories) to limit the spread of solutions. The sections were
treated with Pretreat-4 protease solution for 20 min at
room temperature and slides washed twice with distilled
water. In one set of samples, target probes for Mm-Cck
(gene ID 12424, catalog #402271) and Mm-Gad1 (gluta-
mate decarboxylase 1, GAD-67; gene ID: 14415, catalog
#400951-C2) were spread evenly with a pipette tip on the
sections, and the slides were incubated at 40°C for 2 h in
a hybridization oven (model HybEZ, Advanced Cell Diag-
nostics). A second set of samples were treated with Mm-
Cck and Mm-Slc17a7 (VGluT1; gene ID 72961, catalog
#416631-C2). These probes and those described below
were obtained from Advanced Cell Diagnostics.
Sections were next treated with amplifier and fluores-
cent probes to separately label each gene (AMP1 at 40°C
for 30 min; AMP2 at 40°C for 15 min, AMP3 at 40°C for 30
min, and AMP4 AltB at 40°C for 15 min). Slides were
washed twice with 1 wash buffer according to the man-
ufacturer’s guidelines between incubation steps. Finally,
the sections were incubated for 20 s with DAPI at room
temperature, and then coverslipped with Vectashield Hard-
Set fluorescent mounting medium (Vector Laboratories).
For each brain, separate sections were processed as
either (1) a negative control to confirm the absence of
background labeling on each channel using a bacterial
mRNA (DapB of Bacillus subtilis strain; 3-plex Negative
Control Probe, catalog #320871), or (2) a positive control
to confirm the ability to detect the presence of labeling on
each channel, using three housekeeping genes [RNA
polymerase II subunit A (Polr2a), peptidylprolyl isomerase
B (Ppib), ubiquitin C (Ubc); 3-plex Positive Control Probe,
catalog #320881]. Images of the BA were obtained on
405-, 488-, 550-nm fluorescent channels using a confocal
microscope (model LSM 700, Carl Zeiss Microscopy LLC)
under a Plan-Apochromat 20/0.8 M27 objective.
Immunohistochemistry
Immunostaining for GABAergic and glutamatergic markers
At least five weeks after delivery of AAVdj-hSyn-Con/
Fon-hChR2(H134R)-EYFP-WPRE, mice were terminally
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overdosed with ketamine/xylazine and transcardially per-
fused first with saline followed by ice cold 4% parafor-
maldehyde (PFA) in phosphate buffer, and after removing
the brain from the skull an overnight postfixation took
place at 4°C. Coronal sections (50-m-thick) were cut
using a vibratome (model VT1000S, Leica Biosystems) in
0.1 M phosphate buffer and incubated in 0.8% sodium
borohydride for 30 min. The sections were rinsed in PBS
and blocked for 2 h in a solution containing 0.2% Triton
X-100, 10% normal goat serum, and 2% bovine serum
albumin. Sections were then rinsed and incubated over-
night at 4°C with chicken anti-green fluorescent protein
(GFP; 1:1000, catalog #ab13970, Abcam)/mouse anti-CCK
(1:250, catalog #CCK8-MO-167-1, Frontier Institute), GFP/
mouse anti-Ca2/calmodulin-dependent protein kinase II
(CaMKII; 1:500, catalog #10011437, Cayman Chemical), or
GFP/mouse anti-Gad67 (1:500, catalog #MAB5406, Milli-
poreSigma, or catalog #ab26116, Abcam), GFP/rabbit
anti-Gad67 (1:500, catalog #Af260, Frontier Institute) in
PBS containing 0.2% Triton X-100, 1% normal goat se-
rum, 0.1% sodium azide.
The next day, sections were re-rinsed and incubated for
2 h at room temperature in either (for the GFP/CCK com-
bination) Alexa Fluor 488 (goat anti-chicken, 1:2000, cat-
alog #A11039, Life Technologies)/Alexa Fluor 555 (goat
anti-rabbit, 1:2000, catalog #A21428, Life Technologies),
or (for the GFP/Gad67 and GFP/CaMKII combinations)
Alexa Fluor 488 (goat anti-chicken, as above)/Alexa Fluor
555 (goat anti-mouse, 1:2000, catalog #A21422, Life Tech-
nologies). The sections were then re-rinsed, mounted, and
coverslipped with Vectashield HardSet mounting media
(Vector Laboratories). Images of the BA were obtained on
405-, 488-, 550-nm fluorescent channels using a confocal
microscope (model LSM 700, Carl Zeiss Microscopy) under
a Plan-Apochromat 20/0.8 M27 and Plan-Apochromat
63/1.40 Oil DIC objectives.
Immunostaining for IN subtype markers
At least five weeks after delivery of AAVdj-hSyn-Con/
Fon-hChR2(H134R)-EYFP-WPRE, mice were terminally
overdosed with ketamine/xylazine and transcardially per-
fused first with saline followed by ice cold 4% PFA in
phosphate buffer. After removing the brain from the skull
postfixation took place at 4°C for 3 h. Coronal sections
(50-m-thick) were cut using a vibratome (model VT100S,
Leica Biosystems).
To reveal the immunoreactivity for different markers,
sections containing the BA were further processed for
immunostaining with the following antibody mixtures: rab-
bit anti-CaMKII (1:1000, catalog #ab52476, Abcam) and
guinea pig anti-PV (1:10,000, catalog #195004, Synaptic
Systems), rabbit anti-NPY (1:500 courtesy of Prof.
Günther Sperk) and guinea pig anti-nNOS (1:1000, cata-
log #nNOS-GP-Af740, Frontier Institute), rabbit anti-NPY
(1:500) and guinea pig anti-PV (1:10,000), or rabbit anti-PV
(1:5000, catalog #PV25, Swant Antibodies, Marly, Switzer-
land) and guinea pig anti-Calb (1:3000, catalog #14004,
Synaptic Systems).
To visualize these antibodies, Cy3-conjugated donkey
anti-rabbit antibody (1:500, catalog #711-166-152, Invit-
rogen) and Cy5-conjugated donkey anti-guinea pig (1:
500, catalog #706-175-148, The Jackson Laboratory)
were used. In addition, we incubated different sections in
rat anti-SOM (1:500, catalog #MAB354, MilliporeSigma)
or in rabbit anti-CB1R, which stains only the CB1R-
expressing GABAergic axon terminals (1:1000, catalog
#10006590, Cayman Chemicals). The localization of these
antigens was visualized with Cy3-conjugated donkey
anti-rat (1:500, catalog #712-165-153, Jackson Immu-
noResearch) or DyL405-conjugated goat anti-rabbit (1:
500, catalog #111-475-003, Jackson ImmunoResearch).
A confocal microscope (model C2, Nikon Instruments
Europe BV) was used to obtain images of soma (under a
Plan-Apochromat 20 objective (N.A. 0.75, z step size: 1
m, xy: 0.62 m/pixel) and axon terminals (under a Plan-
Apochromat VC 60 objective (N.A. 1.4, z step size: 0.5
m, xy: 0.21 m/pixel). Those neurons that showed EYFP
immunoreactivity in both the cytoplasm and cell mem-
brane were considered EYFP and could be clearly dis-
tinguished from those EYFP- neurons that soma and
proximal dendrites were surrounded by axonal varicosi-
ties expressing EYFP.
Ex vivo optogenetics
Electrophysiological slice recordings
Ten to 12 weeks after injection of the INTRSECT-ChR2
virus, mice were deeply anesthetized with isoflurane, the
brain was quickly removed and placed into ice-cold so-
lution containing: 252 mM sucrose, 2.5 mM KCl, 26 mM
NaHCO3, 0.5 mM CaCl2, 5 mM MgCl2, 1.25 mM
NaH2PO4, 10 mM glucose, bubbled with 95% O2/5% CO2
(carbogen gas). Horizontal 200-m thick brain sections
containing the BA were prepared with a vibratome (model
VT1200S, Leica Biosystems) and kept in an interface-type
holding chamber containing ACSF at 36°C that gradually
cooled down to room temperature. ACSF contained the
following: 126 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4,
2 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, and 10 mM
glucose, bubbled with carbogen gas. After at least a
60-min-long incubation, slices were transferred to a
submerged-type recording chamber and perfused with
32–34°C ACSF with a flow rate of 2–2.5 ml/min.
Recordings were performed under visual guidance us-
ing differential interference contrast microscopy (via a
model FN-1 Nikon upright microscope) using 40 water
dipping objective. EYFP expression was visualized with
the aid of a mercury arc lamp and a CCD camera (Andor
Technology). Neurons that did not express EYFP were
recorded where EYFP fibers were densest. Patch pi-
pettes (5–7 M) for whole-cell recordings were pulled
from borosilicate capillaries with inner filament (thin
walled, OD 1.5) using a P1000 pipette puller (Sutter In-
strument). In whole-cell recordings the patch pipette con-
tained a K-gluconate based intra-pipette solution
containing the following: 115 mM K-gluconate, 4 mM
NaCl, 2 mM Mg-ATP, 20 mM HEPES, 0.1 mM EGTA, 0.3
mM GTP (sodium salt), and 10 mM phosphocreatine ad-
justed to pH 7.3 using KOH, with an osmolarity of 290
mOsm/l. The pipette also contained 0.2% biocytin. Re-
cordings were performed with a Multiclamp 700B ampli-
fier (Molecular Devices), low-pass filtered at 3 kHz,
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digitized at 10 kHz, recorded with Clampex 10.4 (Molec-
ular Devices), and were analyzed with Clampfit 10.4 (Mo-
lecular Devices) and OriginPro 2015 (OriginLab Corp).
Whole-field blue light (447 nm) laser illumination (Roith-
ner Laser Technik, Vienna, Austria) was applied for 100
ms using a Digital Mirror Device based pattern illuminator
(Mightex Polygon 400, Mightex Systems) to activate even
those neurons expressing ChR2 that membrane time con-
stants are rather slow. The recorded neurons were
clamped at a holding potential of –50 mV. Series resis-
tance was in the range of 15–25 M. For peak and area
analysis, five consecutive traces were averaged. Drug
effects were evaluated after a 10-min wash-in of bath-
applied gabazine (5 M), CGP 5699A (1 M), and CP
55,940 (2 M), or after 20-min wash-in of bath-applied
AM251 (2 M). The peak amplitude for the fast and slow
components was determined at distinct time points (n 
23). The area of these two components was calculated
only for those events in which the fast component was
blocked by gabazine (n  10): the remaining slow com-
ponent was subtracted from the original trace resulting in
the area for the fast component. For firing pattern analy-
ses, EYFP neurons were recorded in current clamp
mode at a holding potential of –65 mV. Voltage responses
were tested to a series of hyperpolarizing and depolariz-
ing square current pulses of 800-ms duration and ampli-
tudes between –100 and 100 pA at 10-pA step intervals,
then up to 300 pA at 50-pA step intervals and finally up to
600 pA at 100-pA step intervals.
Postrecording IN subtype identification
Biocytin content was visualized using Cy3-conjugated
streptavidin (1:10,000, catalog #S6402, Sigma-Aldrich)
and confocal images of the filled cells were obtained
using a confocal microscope (Nikon model C2) under a
Plan-Apochromat VC 20 objective (N.A. 0.75, z step
size: 1 m, xy: 0.40 m/pixel). Cells were immunostained
with antibodies selected on the bases of a combination of
their firing characteristics and the features of their den-
dritic and axonal arbors. Putative CCK basket cells were
immunostained with goat anti-CB1R antibody (1:1000,
catalog #CB1-Go-Af450, Frontier Institute) and visualized
using DyL405-conjugated donkey anti-goat antibody (1:
500, catalog #705-475-003, Jackson ImmunoResearch).
Only those cells (five of seven) expressing CB1R in their
axonal terminals were categorized as CCK basket cells.
Putative fast spiking PV cells were immunostained
with rabbit anti-PV (1:5000, catalog #PV25, Swant) visu-
alized with A647-conjugated donkey anti-rabbit (1:500,
catalog #711-605-152, Jackson ImmunoResearch), and
chicken anti-Calb (1:5000, catalog #214006, Synaptic
Systems) visualized with DyL405-conjugated donkey anti-
chicken (1:500, catalog #703-475-15, Jackson Immu-
noResearch). Confocal images (see below) were taken to
assess Calb and PV co-expression at axonal terminals.
Those cells (three of nine) co-expressing Calb and PV at
their axonal boutons were categorized as PV basket
cells, whereas those cells (six of nine) which expressed
PV, but not Calb, at their axon terminals were considered
axo-axonic cells.
To further confirm the latter classification, in vitro slices
containing both PV basket cells and axo-axonic cells
were re-sectioned into 30 m-thick sections, pepsin di-
gested as described previously (Veres et al., 2014) and
immunostained using a mouse anti-ankyrin G antibody
(1:100, catalog #75-146, NeuroMab) visualized with an
Alexa Fluor 488-conjugated donkey anti-mouse antibody
(1:500, catalog #A21202, Millipore). Those cells which
showed cartridges of axonal terminals in close apposition
to ankyrin G profiles were confirmed as axo-axonic
cells. Because the cells selected for recording and sub-
sequent biocytin filling based on being EYFP, there was
a low level of EYFP fluorescence in their axonal terminals.
In these images, the red channel containing the signal of
the Cy3-conjugated streptavidin used to visualize the bio-
cytin was subtracted from the green channel, and the
axonal terminal apposition to ankyrin G profiles was
evaluated in these modified images merged with the orig-
inal image taken in red channel. All images were obtained
using a confocal microscope (Nikon model C2) under a
Plan Apo VC 60 objective (N.A. 1.4, z step size: 0.15–0.2
m, xy: 0.08–0.10 m/pixel).
In vivo optogenetics
In vivo photostimulation and photosilencing
For photostimulation, blue light (  473 nm) was bilat-
erally shone on the BA at 20 Hz, in 5-ms pulses, consis-
tent with commonly used ChR2-excitation parameters
and mimicking the activity of highly active neurons. For
photosilencing, green light (  532 nm) was bilaterally
shone on the BA continuously, which is also in line with
commonly used Arch-excitation parameters. For IN-
TRSECT experiments in CCK IN mice, laser power was
set to 7 mW both for blue and green laser, measured at
the tip of optic fiber. For the ChR2-photostimulation ex-
periment in CCK-Cre mice, the laser power was reduced
to 3 mW after pilot data showed 7-mW produced indica-
tions of seizure activity. Laser power was calibrated be-
fore each experiment by measuring the power at the tip of
the patch cord with a PM100D optical power meter with
an S120C sensor (Thorlabs) and multiplying that power by
the transmittance of the ferrule connection on each optic
fiber.
Behavioral testing
Fear conditioning and extinction testing was conducted
(Whittle et al., 2010) at least four weeks after virus deliv-
ery. Before testing, each mouse was handled for 2 min/d
for 6 d and habituated to the connected optic-fiber cables
in the home cage for 40 min/d for 3 d.
Fear conditioning
Fear conditioning was conducted in context A: a 30 
25  25 cm operant chamber (Med Associates, Inc.) with
metal walls and a metal rod floor. To provide an additional
olfactory cue, the chamber was cleaned between sub-
jects with a 79.5% water: 19.5% ethanol: 1% vanilla
extract solution. Beginning after a 120- to 180-s stimulus-
free period, there were 3 pairings (60- to 90-s interpair-
ing interval) between a 30-s, 80-dB white noise cue (CS)
and a 2-s 0.6-mA scrambled co-terminating footshock
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(US) followed by a 120-s stimulus-free period. The Med
Associates Video Freeze Monitor System controlled CS
and US presentation.
Fear extinction training
Fear extinction training occurred the following day in
context B: a 27  27  14 cm operant chamber with
transparent walls and a floor covered with wood chips,
cleaned between subjects with a 99% water:1% acetic
acid solution and housed in a different room from training.
After a 180-s stimulus-free baseline, there were 50 30-s
CS presentations (5-s inter-CS interval). During each CS,
light (blue for photostimulation, green for photosilencing)
was shone on the BA.
Extinction retrieval
Extinction retrieval was tested the day after extinction
training in context B, via 5  30-s no-light CS presenta-
tions (5-s inter-CS interval) beginning after a 180-s
stimulus-free baseline. Mice were connected to the fiber
cables during the retrieval test, to control for the influence
of a potential extinction-context cue.
Freezing, the absence of any visible movement except
respiration, was scored from video every 5 s throughout
testing by an experienced observer blind to genotype. The
mean number of freezing observations per baseline pe-
riod and 5 CS block was converted to a percentage
[(number of freezing observations/total number of obser-
vations per period)  100] for analysis. Mice with freezing
scores on any CS-block that were3 SDs from the group
mean were excluded from the analysis.
Novel open field test
Mice were tested in the novel open field test for explor-
atory locomotion and anxiety-like behaviors (Fitzgerald
et al., 2010) 7 d after the completion of fear and extinction
testing. The apparatus was a square arena (39  39 
35 cm) with opaque white Plexiglas walls and floor
(	95 lux). Mice were connected to the fiber optic cables
and placed in the center for a 10-min test session, during
which light (blue for photostimulation, green for photosi-
lencing, as above) was shone on the BA for 2  2-min
periods, interspersed with 2-min light-off periods (i.e.,
off-on-off-on-off). Total distance traveled, average move-
ment speed and time spent in a 25-cm2 center zone was
measured by the EthovisionXT videotracking system (Nol-
dus Information Technology).
Postbehavior confirmation of fiber placement and
virus expression
At the completion of behavioral testing, mice were ter-
minally overdosed with ketamine/xylazine and transcardi-
ally perfused with PBS, then 4% PFA. After overnight
suspension in 4% PFA, followed by 0.1 M phosphate
buffer for 1–2 d at 4°C, 50-m coronal sections were cut
with a vibratome (Leica Biosystems). Sections were
mounted and coverslipped with Vectashield HardSet
mounting medium with 4=,6-diamidino-2-phenylindole
(Vector Laboratories) and imaged with a fluorescent
(model BX41, Olympus America, Inc.) or confocal micro-
scope (model LSM 700, Carl Zeiss Microscopy) under a
Plan-Apochromat 20/0.8 M27 objective.
Statistical analysis
Group effects in electrophysiological experiments were
analyzed using paired t test. For scatterplots, each sym-
bol represents the mean average of five consecutive
events. Group effects in behavioral experiments were
analyzed using Student’s t test or ANOVA, depending on
the number of groups, followed by Fisher’s LSD post hoc
tests paired Student’s t test. The threshold for statistical
significance was set at p 
 0.05. Values given in the
Results represent the mean  SEM.
Results
Intersectional strategy for neuronal targeting
To gain selective genetic access to CCK INs, a double-
transgenic mouse line was generated by intercrossing a
CCK-Cre driver line with a Dlx5/6-Flpe driver line, which
expresses Flp recombinase in most cortical GABAergic
neurons (Miyoshi and Fishell, 2011; Taniguchi et al., 2011;
Vogel et al., 2016; Fig. 1A). We then used an intersectional
optogenetic viral strategy to visualize and control the
targeted cells, involving the bilateral injection of CCK IN
double-transgenic mice with INTRSECT viruses transfect-
ing cells with EYFP-tagged ChR2 in a manner conditional
on the presence of both Cre and Flp recombinases (Fenno
et al., 2014; Fig. 1B,C). Initial, non-quantitative immuno-
cytochemical staining for the GABAergic neuronal marker,
GAD67, indicated co-localization with EYFP cells in the
BA (Fig. 1D). Similarly, fluorescence in situ hybridization
showed that EYFP expression appeared concordant with
the labeling of BA cells that were also positive for Cck and
Gad1 mRNA probes (Fig. 1E).
Targeted neurons are GABAergic
To further assess the selectivity of the intersectional
targeting approach employed, we performed ex vivo elec-
trophysiological recordings in CCK IN mice transfected
with the INTRSECT-ChR2 virus (Fig. 2A–C). Whole-cell
recordings from EYFP-negative, likely PNs (n 23), which
were postsynaptic to EYFP-expressing neurons in BA-
containing brain slices, revealed that blue light illumina-
tion evoked outward currents, but with substantial
variance both in the peak amplitude and decaying phase
(Fig. 2D,G). Further inspection of these responses indi-
cated that in some cases, the light-evoked currents
clearly had fast and slow components, recognized by
distinct peaks (Fig. 2E). The two outward components had
significantly different peak amplitude (fast component:
201.6  27.8 pA, slow component: 63.6  10.7 pA, n 
23, t(43)  4.55, p 
 0.001; Fig. 2G), but they carried
similar charge (fast component: 18.4  6.2 pC, slow
component: 8.4  2.2 pC, n  10, p  0.1; Fig. 2J).
We then performed pharmacological manipulations
showing that the fast component was blocked by the
GABAA receptor antagonist, gabazine (peak amplitude in
control: 202.3  50.3 pA; in gabazine: 2.0  0.5 pA, n 
10, t(9)  3.99, p  0.003; Fig. 2F,H). Conversely, the
remaining slow outward current was eliminated by the
GABAB receptor antagonist, CGP 5699A (peak amplitude
in gabazine: 47.9  20.4 pA, in CGP 5699A: 1.2  0.8 pA,
n  4, t(3)  2.38, p  0.04; Fig. 2F,I). No inward (i.e.,
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excitatory synaptic current) was evident in any recordings,
even in the presence of both GABA receptor antagonists;
indicating that photostimulation exclusively evoked inhib-
itory, GABA receptor-mediated synaptic currents in BA
neurons, consistent with the selective targeting of INs,
and not PNs, in this region.
Targeted neurons express functional CB1R
Based on earlier reports that CCK-containing basket
cells in the BA express CB1R, we next asked whether the
targeted BA INs were CB1R-positive (Katona et al., 2001;
McDonald and Mascagni, 2001a; Vereczki et al., 2016;
Veres et al., 2017). To test the responsivity of the targeted
cells to CB1R activation, we generated light-evoked post-
synaptic currents (PSCs) in EYFP-negative cells followed
by bath application of the CB1R agonist, CP 55,940. The
application of the agonist reduced the peak amplitude of
light-evoked events by 50% (control: 209.8  88.4 pA, in
CP: 112.6  47.6 pA, peak ratio: CP/ctr: 51.3  5.4%, n
 5, t(4)  2.35, p  0.039; Fig. 2K,L). We verified that the
CP 55,940-induced reduction was CB1R mediated by
abolishing the effect via preincubation with the CB1R
antagonist, AM251 (peak amplitude in AM251: 261.8 
70.2 pA, in AM251  CP 55,940: 259.5  78.4 pA, peak
ratio: AM251  CP 55,940/AM251: 96.7  8.9%, n  4, p
 0.89; Fig. 2M,N). These data demonstrate that a signif-
icant component of synaptic currents in BA neurons
evoked by light illumination in slices stems from signaling
through the CB1R. Consistent with these findings, immu-
nostaining BA sections containing transfected processes
revealed that 	40% of EYFP-expressing axonal varicos-
ities were positive for CB1R (Fig. 2O–R). These results
indicate that a significant proportion of the targeted cells
exhibit a defining feature of CCK-expressing basket cells.
Subsets of targeted INs express NPY or PV
While our findings indicate that a substantial proportion
of the targeted cells had properties of CCK/CB1R-
expressing basket cells, two observations led us to won-
der whether other IN populations were also targeted.
First, light-evoked responses were not fully blocked by
CB1R agonism, in contrast to earlier recordings obtained
in BA (Vogel et al., 2016) and second, they displayed a
prominent GABAB receptor-mediated component in the
light-evoked outward current that is uncharacteristic of
basket cells (Vogel et al., 2016; Rovira-Esteban et al.,
2017; Veres et al., 2017).
This led us to perform immunolabeling for presence of
various IN neurochemical markers in EYFP-expressing
cells. We found that 	29% of EYFP cells expressed
NPY (19 NPY out of 65 EYFP neurons) and 	17%
expressed PV (14 PV out of 82 EYFP neurons; Fig.
3A–C), whereas none of them expressed SOM (0 out of 33
EYFP neurons) or nNOS (0 out of 41 EYFP neurons;
data not shown). Of note, PV and NPY only rarely co-
expressed in the same neurons (1 PV neuron co-
expressed NPY out of 174 PV neurons, while one NPY
neuron contained PV out of 96 NPY neurons), consis-
Figure 1. Intersectional strategy for targeting BA INs. A, Schematic of the intersectional strategy used to target BA INs in
CCK-Cre;Dlx5/6-Flp double-transgenic mice with (B) INTRSECT pAAV-nEF1a-Con/Fon-hChR2(H134R)-EYFP-WPRE virus. C, Rep-
resentative example of EYFP expression after virus transfection (scale bar  100 m). D, Virus-transfected (EYFP-expressing) cells
immunopositive for GAD67 (white arrows, scale bar  10 m). E, Virus-transfected (EYFP-expressing) cells labeled with Cck and
Gad1 mRNA; arrows denote two example neurons positive for EYFP, Cck, and Gad1 (white arrows, scale bar  10 m).
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Figure 2. Photostimulation of GABAergic cells in the BA. A, Schematic drawing showing the intersectional viral strategy used to target
CCK INs in CCK-Cre;Dlx5/6-FLP double-transgenic mice. B, Example of INTRSECT AAVdj-hSyn-Con/Fon-hChR2(H134R)-EYFP-
WPRE (INTRSECT-ChR2) expression in the BA (CeA  central amygdala). C, Schematic drawing represents a horizontal slice with
viral expression shown in green (Hip  hippocampus). Whole-cell patch clamp recordings were performed in non-green cells, likely
in PNs in slices prepared from double-transgenic mice injected with AAV containing INTRSECT-ChR2. D, E, Averaged traces of five
consecutive PSCs obtained in three different neurons evoked by light illumination (blue arrow). High variability both in peak amplitude
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tent with prior studies (Ma nko et al., 2012). We also
detected Calb in some of PV/EYFP-expressing neurons
(three of seven; Fig. 3B). Previous studies have estab-
lished that Calb content of PV INs identifies the neuron
as a basket cell (McDonald and Betette, 2001), as distin-
guished from PV INs lacking this Ca2-binding protein,
which are axo-axonic cells (Bienvenu et al., 2012; Verec-
zki et al., 2016; Andrási et al., 2017). Finally, in line with our
in situ hybridization and electrophysiological data, none of
the EYFP-expressing cells examined (n  51) were immu-
nopositive for a glutamatergic neuronal maker, CaMKII
(Fig. 3D).
Targeted INs are morphologically diverse
Our immunolabeling results suggest that, in addition to
CCK/CB1R-expressing basket cells, three IN subtypes:
PV basket cells, PV axo-axonic cells and NPY, likely
neurogliaform cells (NGFCs), were targeted. To substan-
tiate this, we intracellularly-labeled and immunostained
EYFP neurons obtained from our slice preparations to
allow for a direct comparison between the firing proper-
ties and neurochemical phenotype of each cell (Fig. 4A).
Of 33 EYFP cells labeled, all had dendritic and axonal
morphologic features consistent with INs and not PNs.
Examination of these cells based on the action potential
width at half maximum, 50% decay time of the after-
hyperpolarization (AHP) and maximum firing rate led us to
classify three main subcategories which, in turn, corre-
sponded well to differences in their respective immuno-
cytochemically features (Fig. 4B).
One group was characterized by a fast-spiking pheno-
type (i.e., narrow action potential and high, 100-Hz fir-
ing-rate; Fig. 4C). Within this group, both PV basket
cells (n 3; Fig. 4D) and PV axo-axonic cells (n 5; Fig.
4E) were identifiable; the former showed immunoreactivity
for Calb and avoided the axon initial segments visualized
by Ankyrin G staining, while the latter lacked Calb and
their axonal varicosities formed close appositions with
continued
(D) and decaying phase (D, E) is typical for events evoked in different neurons. The traces in E are peak scaled. Dashed lines show
where the peak amplitude for fast and slow components of evoked currents was measured. F, Traces from an experiment measuring
the antagonist-sensitivity of light-evoked responses. Gabazine (5 M) wash-in eliminated the fast GABAA-mediated component, while
CGP 5699A (1 M) blocked the remaining slow GABAB-mediated component. Importantly, no inward, i.e., EPSC, could be observed
in the presence of the GABA receptor antagonists, indicating that the applied intersectional strategy allowed us to excite selective
GABAergic cells. G, Peak amplitude of the fast components in evoked responses measured in the same neurons was significantly
larger than the peak amplitude of the slow components. H, The fast components were blocked by bath application of gabazine
(paired t test). I, The slow components were eliminated by CGP 5699A wash-in. J, The area, i.e., the charge of the fast and slow
components evoked in the same neurons, was not different. GABAA receptor-mediated fast responses were isolated by subtracting
the responses recorded in the presence of gabazine from the control traces and their area was measured. Example traces (subtracted)
are shown in F. The area of the GABAB receptor-mediated slow components were determined on the traces recorded in the presence
of gabazine. K, Averaged traces taken from an example experiment indicate that the light-evoked PSCs are smaller on wash-in of a
CB1R agonist, CP 55,940 (2 M). L, In all experiments tested, bath application of CP 55,940 significantly reduced the peak amplitude
of the fast component. M, Averaged traces taken from an experiment showing that, in the presence of the CB1R antagonist, AM251
(2 M), bath application of CP 55,940 (2 M) did not cause a reduction in the peak amplitude. N, Preincubation of the slices in AM251
prevented the CP 55,940-induced reduction of the peak amplitude of light-evoked postsynaptic responses. O–Q, A portion of
EYFP-expressing axon terminals is immunoreactive for CB1 (arrows). R, Approximately 40% of EYFP-expressing axonal varicosities
were immunopositive for CB1R (156 EYFP varicosities were tested in two mice); p 
 0.05 fast versus slow, gabazine versus
control (Ctr), CGP versus in gabazine (Gab), CP versus Ctr. n.s., non-significant.
Figure 3. GABAergic cells labeled with intersectional viral strategy represent different populations of INs. A, Example of EYFP-
expressing cells (panel A1) that either are (panel A2, arrow) or are not (panel A3, asterisk) also immunopositive for NPY (scale bar 
10 m). B, Example of two EYFP-expressing cells (panel B1, arrow and arrowhead) that both contain PV (panel B2), but only one of
which is also immunopositive for Calb (panel B3, arrow; scale bar  10 m). C, Pie chart showing the ratio of EYFP-expressing
neurons that contain PV or NPY. Note a large proportion of cells does not express either PV or NPY. D, Example of EYFP-expressing
cell (panel D1, asterisk) and non-overlapping cells immunopositive for CaMKII (panels D2, D3; scale bar  10 m).
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axon initial segments. A second group discharged action
potentials with an intermediate width and at the lowest
rate. The cells in this group had axonal varicosities immu-
nopositive for CB1R, identifying them as CCK/CB1-
expressing basket cells (n  5; Fig. 4F). The third last
group had the widest action potentials and longest AHP
Figure 4. Action potential features distinguish GABAergic cell types labeled with intersectional viral strategy. A, Schematic drawing
depicts a horizontal slice with viral expression shown in green (Hip  hippocampus). Whole-cell patch clamp recordings were
performed in INTRSECT-ChR2-transfected GABAergic cells (green circles) visualized by blue light illumination. B, Traces exemplifying
differences in the full width at action potential half maximum (FWHM), 50% decay of AHP and maximum firing rate for the three
electrophysiologically distinct IN groups: fast-spiking INs (FS INs) in orange, CCK basket cells (CCKBCs) in blue, and NGFCs in cyan.
C, 3D plot showing the separation of 33 intracellularly labeled EYFP INs based on the three action potential parameters. D–G,
Examples of four distinct types of EYFP-expressing INs intracellularly filled by whole-cell recording in vitro. In each case, a maximal
intensity projection of a 3D confocal image of the labeled INs is shown together with its firing pattern and the EYFP expression
at the soma level. D, An example for a PV basket cell (PVBC) identified based on its firing pattern, Calb and PV positivity in
its axonal boutons (white arrows in insets) and forming no close appositions (red arrows) with ankyrin G (AnkG)-labeled axon
initial segments (delimited by green arrowheads). E, An example for a PV axo-axonic cell (AAC) identified based on its firing
pattern, PV positivity and Calb negativity in its axonal boutons (white arrows in insets) and forming close appositions by its
axonal boutons (red arrows) with an AnkG-labeled axon initial segment (delimited by green arrowheads). F, An example for a
CCKBC identified based on its firing pattern and on the CB1 content in its axonal boutons (white arrows in insets). G, An example
of a NGFC based on its dendritic and axonal morphology and characteristic firing pattern. H, Pie chart showing the ratio of
identified IN types in a group of EYFP-expressing neurons in the BA that were randomly sampled in slice preparations. For D–G
depictions of maximal intensity projections of intracellularly filled cells, scale bar  40 m, insets  5 m; firing pattern scale
bar x-axis  100 ms, y-axis  10 mV.
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and were identifiable as NGFCs based on previously pub-
lished results (Tamás et al., 2003; Armstrong et al., 2012;
Ma nko et al., 2012; n  20; Fig. 4G). Indeed, quantifica-
tion revealed the majority (	60%) of the in vitro recorded and
labeled cells fell into the latter, NGFC, subclass, with roughly
equal (	9–15%) proportions in the other classes (Fig. 4H).
Photostimulating targeted INs facilitates fear
extinction
Our next experiments assessed the contribution of the
targeted population of BA INs to fear extinction. BA INs
were infected with INTRSECT-ChR2 (Fig. 5A), INTRSECT-
Arch, or an INTRSECT-EYFP control virus, and tested for
fear conditioning, extinction training and extinction re-
trieval over consecutive days, using our standard extinc-
tion training protocol (Bukalo et al., 2015). For fiber
placement maps see Extended Data Figure 5-1. During
extinction training (only), blue or green light, respectively,
was shone concomitant with each CS presentation.
In all groups, freezing increased significantly from the
first to third and final US-paired CS during conditioning
(ANOVA effect of CS: F(1,28)  67.31, p 
 0.001; effect of
group: F(2,28)  0.07, p  0.934; CS  group interaction:
F(2,28)  0.13, p  0.883; Fig. 5B). On extinction training,
freezing decreased across CS trial-blocks (ANOVA effect
of CS: F(1,28)  19.76, p 
 0.001; effect of group: F(2,28) 
0.99, p  0.385; CS  group interaction: F(2,28)  0.58,
p  0.565; Fig. 5B).
During light-free extinction retrieval the following day,
there was an overall decrease in freezing on extinction re-
trieval, as compared to the first trial-block of extinction train-
ing (ANOVA effect of CS: F(1,28)  9.24, p  0.005; effect of
group: F(2,28)  2.88, p  0.073; CS  group interaction:
F(2,28)  1.90, p  0.169; post hoc paired t test retrieval vs
training-trial comparisons for EYFP: t(12)  1.81, p  0.095;
ChR2: t(8)  3.20, p  0.013, eArch3.3: t(8)  0.37, p 
0.719). The INTRSECT-ChR2 group exhibited significantly
less freezing than INTRSECT-EYFP controls, or the
INTRSECT-eArch group (effect of group: F(2,28)  7.29, p 
0.003; post hoc comparisons for EYFP vs ChR2: p 0.043;
ChR2 vs eArch: p 
 0.001; Fig. 5B), consistent with the
facilitation of extinction memory formation.
Non-selectively photostimulating or photosilencing
BA CCK cells disrupts fear extinction
Given the observation of an extinction-facilitating effect
of photostimulating BA INs, we wondered how this effect
would compare with the effect of manipulating a combi-
nation of BA INs and BA CCK-expressing glutamatergic
neurons. We transfected cells of single-transgenic CCK-
Cre mice in the BA with Cre-dependent ChR2, eArch3.0
or an EYFP control virus (Fig. 6A,B). Given the majority of
amygdalar glutamatergic neurons express CCK (Allen
Brain Institute, experiment: 77869074), we expected the
effect of non-selectively photostimulating BA CCK cells
would largely reflect stimulation of glutamatergic cells and
thereby differ from the effect of BA INs. Using fluores-
cence in situ hybridization we found that following virus
injections into the BA, EYFP-labeled neurons were posi-
tive for Cck mRNA and that some of these cells showed
labeling for Gad1 and other for Slc17a7, consistent with
the transfection of both CCK INs and PNs (Fig. 6C,D;
Andrási et al., 2017).
We next performed fear conditioning and extinction
testing (as above). For fiber placement maps see Ex-
tended Data Figure 6-1.
Freezing was significantly higher on the third CS than
the first CS during fear conditioning, with no difference
between groups (ANOVA effect of CS: F(1,52)  182.05, p

 0.001; effect of group: F(2,52)  1.26, p  0.29; CS 
group interaction: F(2,52)  0.61, p  0.55; Fig. 6F). On
extinction training, freezing decreased across CS trial-
blocks in the EYFP and eArch3.0 groups and the ChR2
group froze less on the first trial-block than EYFP controls
(ANOVA effect of CS: F(1,52)  27.71, p 
 0.001; effect of
group: F(2,52)  6.74, p  0.003; CS  group interaction:
F(2,52)  3.11, p  0.053, followed by post hoc compari-
son of ChR2 vs EYFP on the first trial-block: p 
 0.001;
last trial-block; Fig. 6F).
There was a decrease in freezing on extinction retrieval,
as compared to the first trial of extinction training, in all
Figure 5. In vivo photostimulation of transfected INs during extinction training. A, Schematic of the intersectional strategy used to target
BA INs in CCK-Cre;Dlx5/6-Flp double-transgenic mice with INTRSECT pAAV-nEF1a-Con/Fon-hChR2(H134R)-EYFP-WPRE or AAVdj-
hSyn-Con/Fon-Arch3.3-EYFP-WPRE virus and shine blue or green light during each CS presentation of extinction-training. For fiber
placement maps see Extended Data Figure 5-1. B, Photoexcitation, but not photoinhibition, during extinction training reduced freezing on
light-free extinction retrieval the following day; n  9–13 per group; p 
 0.05 INTRSECT-ChR2 versus INTRSECT-EYFP. #p 
 0.05 T0
versus T1 extinction training for INTRSECT-ChR2.
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groups (ANOVA effect of CS: F(1,52)  1.09, p  0.302;
effect of group: F(2,52)  3.72, p  0.031; CS  group
interaction: F(2,52)  17.37, p 
 0.001; post hoc paired t
test retrieval vs training-trial comparisons for EYFP: t(26)
5.05, p 
 0.001; ChR2: t(11)  2.87, p  0.015, eArch3.0:
t(15)  2.88, p  0.011). However, freezing differed signifi-
cantly between groups on the subsequent extinction re-
trieval test, with higher freezing in both the ChR2 and
eArch3.0 group, as compared to the EYFP controls (effect of
group: F(2,52)  3.79, p  0.029; post hoc comparisons for
EYFP vs ChR2: p 0.026; EYFP vs eArch3.0 p 0.031; Fig.
6F), indicating an impairment in fear extinction in response to
either silencing or excitation of this neuronal population.
Finally, we used a novel open field test to confirm that the
differences observed in the extinction retrieval were due to
the manipulation of the BA CCK cells participating in fear
circuits, and not to a different locomotor or anxiety level
within the different groups. In this test, groups did not differ
in anxiety-related exploration of the aversive center zone
(effect of group: F(2,43)  8.098, p  0.001) or total distance
traveled in the arena (effect of group: F(2,43)  8.098, p 
0.001; Extended Data Fig. 6-2).
Discussion
There is growing appreciation of the critical contribution
of INs to the regulation of network activity to support
Figure 6. In vivo photostimulation and photosilencing of transfected BA INs and PNs during extinction training. A, Schematic of
approach to targeting BA INs and PNs in CCK-Cre single-transgenic mice with AAV5-Ef1a-DIO-hChR2(H134R)-EYFP-WRPE-pA or
AAV5-Ef1a-DIO-eArch3.0-EYFP. B, Representative example of EYFP expression after virus transfection. C, Virus-transfected
(EYFP-expressing) cells labeled with Cck mRNA, including example of cell labeled with Gad1 mRNA (white arrows, scale bar  20
m). D, Virus-transfected (EYFP-expressing) cells labeled with Cck mRNA, including example of cell labeled with Slc17a7 mRNA
(white arrows, scale bar  20 m). E, Blue (ChR2 group) or green (eArch3.0 group) was shone during each CS presentation of
extinction training. For fiber placement maps see Extended Data Figure 6-1. F, Photoexcitation in the ChR2 group during each CS
presentation of extinction training increased freezing during training and light-free extinction retrieval the following day, relative to
EYFP controls. Photosilencing in the eArch3.0 group during each CS presentation of extinction training reduced freezing on light-free
extinction retrieval the following day, relative to EYFP controls; n  12–27 per group; p 
 0.05, #p 
 0.05 T0 versus T1 extinction
training. Results of similar interventions on locomotion and anxiety level are presented in Extended Data Figure 6-2.
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behavioral functions subserved by the BA, including Pav-
lovian fear and extinction. However, a description of the
subclass of BA INs expressing the neuropeptide, CCK,
has proved elusive. Here, we sought to genetically access
BA CCK INs to define the neurochemical and physiologic
phenotype of these cells and assess their possible con-
tribution to fear extinction.
Using an intersectional approach, entailing transfecting
Cre/Flp cells in CCK-Cre;Dlx5/6-Flpe transgenic mice
with opsin-containing INTRSECT viruses, we selectively
targeted GABAergic INs in the BA and showed that al-
most half of these expressed functional CB1R on their
axonal boutons. In line with this anatomic observation, the
application of a CB1R agonist reduced the amplitude of
light-evoked IPSCs by half. Taken together, this is strong
evidence that a significant portion of the cells targeted by
INTRSECT strategy are CCK-expressing basket cells,
given prior studies have shown that CCK-expressing bas-
ket cells express CB1R on their boutons that, when acti-
vated, markedly suppress inhibitory transmission (Katona
et al., 2001; McDonald and Mascagni, 2001a; Azad et al.,
2004; Vogel et al., 2016; Barsy et al., 2017; Rovira-
Esteban et al., 2017; Veres et al., 2017). This functional
connection between CCK and CB1R has been of partic-
ular interest to the field given compelling evidence linking
endocannabinoid signaling, in the BA and other regions,
to extinction (Patel et al., 2017). One proposal is that
endocannabinoids could inhibit CCK release in the BA
(Beinfeld and Connolly, 2001; Chhatwal et al., 2009) and
thereby oppose the peptide’s pro-fear/anxiety effects to
enable extinction (Frankland et al., 1997; Harro, 2006; Del
Boca et al., 2012; Bowers and Ressler, 2015).
We found that the genetically targeted INs also dis-
played a prominent GABAB receptor-mediated compo-
nent in the light-evoked outward current that likely does
not originate from CCK-expressing basket cells. Indeed,
further examination using a combination of immunostain-
ing, electrophysiological recordings and morphologic in-
spection indicated that targeting CCK cells also included
PV basket cells, PV axo-axonic cells, and NGFCs. A
portion of the latter INs might express NPY (Ma nko et al.,
2012). Based on available data, we conclude that recom-
bination in these cells reflects the genuine presence of
CCK in adult BA cells at low levels that were not detected
by prior studies using other approaches. This conclusion
is based on several observations. First, other recent stud-
ies using genetic approaches also support a significant
diversity of CCK-expressing INs in the BA, among which
INs with NGFCmorphology and firing characteristics were
evident (Jasnow et al., 2009; Vogel et al., 2016; Veres et al.,
2017). Second, CCK mRNA was unequivocally detected in
axo-axonic cells both in the neocortex (Paul et al., 2017)
and hippocampus (Harris et al., 2018) and even in a
portion of hippocampal PV-expressing basket cells (Har-
ris et al., 2018). Third, using a different approach to that
used herein, involving crossing offspring of CCK-Cre and
Nkx2.1-Flp mice with an Ai65 reporter line, another recent
study reported labeling of axo-axonic cells in the neocor-
tex (Paul et al., 2017). Fourth, dense core vesicles are
readily observed in axon terminals of both PV-containing
basket and axo-axonic cells (Takács et al., 2015), indicat-
ing the presence of neuropeptides in these GABAergic
cell types that have not been labeled so far in SOM-Cre,
NPY-Cre, or VIP-Cre mouse lines. Taken together with
these prior observations, our results strongly speak to the
importance of applying multiple phenotypic criteria when
classifying CCK IN cells and underscore the limitations of
demarcating this population based on a single, neuro-
chemical marker (Harris et al., 2018). The difference in
ratio of distinct IN types obtained by immunostaining in
perfused tissue (Figs. 2, 3) and by randomly sampled
neurons recorded in in vitro slices (Fig. 4) may reflect the
fact that some cell types are better able to tolerate the
procedure of slice preparation than others.
The finding that optogenetic photostimulation of the
targeted IN population in the BA produced behavioral
effects is indicative of a facilitation of fear extinction. This
is reminiscent of the recent finding that brain-wide che-
mogenetic activation of a population of INs genetically-
accessed using a CCK-Cre;Dlx5/6-Flpe transgenic
strategy similar to ours, improved performance on mem-
ory tasks (contextual fear and discrimination, social and
object recognition, puzzle box; Whissell et al., 2019). To-
gether, these behavioral effects raise intriguing questions
about the relative contribution of specific subsets of INs
that are targeted by this strategy, given our data show
that the population are not simply “CCK-expressing,” at
least assessed by immunostaining. Earlier studies have
implicated BA INs including NPY-expressing and PV-
expressing cells in extinction (Gutman et al., 2008; Herry
et al., 2010; Verma et al., 2012; Tovote et al., 2015). For
instance, a reduction in GABAergic input from PV-
expressing axo-axonic cells onto BA PNs resulted in an
impaired extinction learning (Saha et al., 2017). However,
whether one specific subset disproportionally contributes
to the extinction-facilitating effects of stimulation remains
to be determined and will be technically challenging to
address, given the lack of exclusive markers for each
given subpopulation. Another important goal will be po-
sitioning the various subclasses into the micro and macro
circuits mediating extinction. Prior work has already dem-
onstrated important functional connections both locally
between different IN subtypes in the BA (Andrási et al.,
2017) and distally, via CCK IN projections to the medial
PFC regions (Senn et al., 2014). In summary, our data
together with recent findings imply that excitation of
GABAergic microcircuits in the BA via local or distal pro-
jections with cortical or subcortical origin could potentially
augment extinction memory formation.
In experiments using single CCK-Cre mice, we targeted a
substantial portion of PNs (in addition to CCK INs) located in
the BA, reflecting the fact thatmost excitatory neurons express
CCK in this nucleus (Rovira-Esteban et al., 2017; see also Allen
Brain Atlas, experiment: 77869074). In contrast to the
extinction-facilitating effects of photostimulating the IN popu-
lation, photostimulation or photosilencing of globally-targeted
(i.e., INs and PNs) BA CCK cells, via Cre-dependent opsin
transfection in CCK-Cre single-transgenic mice, during extinc-
tion training led to an impairment in long-term extinction
memory, as evidenced by higher freezing on a light-free
extinction retrieval test. Of note, photostimulation also re-
duced freezing during initial extinction training (i.e., fear re-
trieval), which suggests either an acute anxiolytic-like
effect or a failure to retrieve the fear memory. Alterna-
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tively, this reduction in freezing could reflect a
photostimulation-induced potentiation of CS-induced es-
cape behaviors, which would be in line with panicogenic
effects of CCK agonism (de Montigny, 1989; Bradwejn
et al., 1991; Kramer et al., 1995). This interpretation awaits
further testing although we did not detect effects of pho-
tostimulation on motor or anxiety-related behaviors in a
novel open field test in which no CS was presented.
Our data obtained in single CCK-Cre mice showing that
photoinhibition of BA neurons impaired fear retrieval are in
line with recent findings using a distinct mouse line, Thy1-
Cre. As in our case, photoinhibition of Thy1-expressing,
mainly PNs in the BA during extinction training resulted in
a weakening in extinction memory formation (McCullough
et al., 2016). These results suggest that BA circuits contain
neural populations able to control fear extinction memory
(Herry et al., 2008).
Impairments in fear extinction are evident in various
neuropsychiatric conditions, including trauma- and
stressor-related disorders and some anxiety disorders.
This has encouraged basic researchers to define the neu-
robiological basis of impaired and intact fear extinction as
a potentially tractable approach to developing new treat-
ments for these disorders. The resultant research has
defined the amygdala as a central node within a distrib-
uted neural system comprising cortical, hippocampal, and
midbrain structures, among others. The current findings
add to a growing literature by describing a unique popu-
lation of INs in the BA that, when activated, exert strong
modulatory effects on extinction.
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